Novopyxis Inc.
Biotechnology company · Cambridge, Massachusetts, United States
Novopyxis Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2013. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $496,791 in total, most recently in 2018. It has reported private securities offerings to the US SEC, most recently $512,932 sold in a notice filed in 2017.
Novopyxis at a glance
What does Novopyxis do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $496,791 in total (2018). NIH funding came from the National Institute of Biomedical Imaging and Bioengineering.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $512,932 sold (2017).
Frequently asked questions about Novopyxis
Where is Novopyxis headquartered?
Novopyxis Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Novopyxis do?
Novopyxis Inc. is a biotechnology company.
When was Novopyxis founded?
The earliest incorporation on record for Novopyxis Inc. is in 2013, according to public company registers.
Similar companies
- Editas Medicine, Inc.Cambridge, Massachusetts, United States
- Moderna, Inc.Cambridge, Massachusetts, United States
- Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
- Beam Therapeutics Inc.Cambridge, Massachusetts, United States
- Genzyme CorpCambridge, Massachusetts, United States
- Neutrolis Inc.Cambridge, Massachusetts, United States
- Biogen Inc.Cambridge, Massachusetts, United States
- Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences